Renal Allograft Survival in Transplant Recipients with Focal Segmental Glomerulosclerosis
dc.contributor.author | Cibrik, Diane M. | en_US |
dc.contributor.author | Kaplan, Bruce | en_US |
dc.contributor.author | Campbell, Darrell A. | en_US |
dc.contributor.author | Kriesche, Herwig-Ulf Meier | en_US |
dc.date.accessioned | 2010-06-01T20:45:01Z | |
dc.date.available | 2010-06-01T20:45:01Z | |
dc.date.issued | 2003-01 | en_US |
dc.identifier.citation | Cibrik, Diane M . ; Kaplan, Bruce; Campbell, Darrell A . ; Kriesche, Herwig-Ulf Meier (2003). "Renal Allograft Survival in Transplant Recipients with Focal Segmental Glomerulosclerosis." American Journal of Transplantation 3(1): 64-67. <http://hdl.handle.net/2027.42/73852> | en_US |
dc.identifier.issn | 1600-6135 | en_US |
dc.identifier.issn | 1600-6143 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/73852 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=12492712&dopt=citation | en_US |
dc.format.extent | 86243 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Munksgaard International Publishers | en_US |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.rights | © Blackwell Munksgaard, 2003 | en_US |
dc.subject.other | 6-antigen Match | en_US |
dc.subject.other | FSGS | en_US |
dc.subject.other | Graft Survival | en_US |
dc.subject.other | Living Donor | en_US |
dc.subject.other | Renal Transplantation | en_US |
dc.subject.other | Zero Mismatch | en_US |
dc.title | Renal Allograft Survival in Transplant Recipients with Focal Segmental Glomerulosclerosis | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Medicine (General) | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Surgery, University of Michigan, Ann Arbor, MI, USA, | en_US |
dc.contributor.affiliationother | Medicine and | en_US |
dc.contributor.affiliationother | Department of Medicine, Division of Nephrology, University of Florida, Gainsville, FL, USA | en_US |
dc.identifier.pmid | 12492712 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/73852/1/j.1600-6143.2003.30111.x.pdf | |
dc.identifier.doi | 10.1034/j.1600-6143.2003.30111.x | en_US |
dc.identifier.source | American Journal of Transplantation | en_US |
dc.identifier.citedreference | Orth SR, Ritz E. The nephrotic syndrome. N Engl J Med 1998; 338: 1202 – 1211. | en_US |
dc.identifier.citedreference | Savin VJ, Sharma R, Sharma M et al. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 1996; 334: 878 – 883. | en_US |
dc.identifier.citedreference | Artero M, Biava C, Amend W, Tomlanovich S, Vincenti F. Recurrent focal glomerulosclerosis: natural history and response to therapy. Am J Med 1992; 92: 375 – 383. | en_US |
dc.identifier.citedreference | Banfi G, Colturi C, Montagnino G, Ponticelli C. The recurrence of focal segmental glomerulosclerosis in kidney transplant patients treated with cyclosporine. Transplantation 1990; 50: 594 – 596. | en_US |
dc.identifier.citedreference | Hariharan S, Adams MB, Brennan DC et al. Recurrent and de novo glomerular disease after renal transplantation: a report from Renal Allograft Disease Registry (RADR). Transplantation 1999; 68: 635 – 641. | en_US |
dc.identifier.citedreference | Feld SM, Figueroa P, Savin V et al. Plasmapheresis in the treatment of steroid-resistant focal segmental glomerulosclerosis in native kidneys. Am J Kidney Dis 1998; 32: 230 – 237. | en_US |
dc.identifier.citedreference | First MR. Living-related donor transplants should be performed with caution in patients with focal segmental glomerulosclerosis. Pediatr Nephrol 1995; 9 ( Suppl. ): S40 – S42. | en_US |
dc.identifier.citedreference | Zimmerman CE. Renal transplantation for focal segmental glomerulosclerosis. Transplantation 1980; 29: 172. | en_US |
dc.identifier.citedreference | Morzycka M, Croker BP Jr, Siegler HF, Tisher CC. Evaluation of recurrent glomerulonephritis in kidney allografts. Am J Med 1982; 72: 588 – 598. | en_US |
dc.identifier.citedreference | Al-Akash SI, Ettenger RB. Kidney transplantation in children. In: Danovitch GM, ed. Handbook of Kidney Transplantation. Philadelphia: Lippincott Williams & Wilkins, 2001: 340. | en_US |
dc.identifier.citedreference | Sayegh MH, Kaplan AA. Focal Glomerulosclerosis: Recurrence After Transplantation. Rose BD, ed. Up-to-date [Version 8.3]. UpToDate Inc., 2000. | en_US |
dc.identifier.citedreference | Baum MA, Stablein DM, Panzarino VM et al. Loss of living donor renal allograft survival advantage in children with focal segmental glomerulosclerosis. Kidney Int 2001; 59: 328 – 333. | en_US |
dc.identifier.citedreference | Abbott KC, Sawyers ES, Oliver JD et al. Graft loss due to recurrent focal segmental glomerulosclerosis in renal transplant recipients in the United States. Am J Kidney Dis 2001; 37: 366 – 373.. | en_US |
dc.identifier.citedreference | Cecka JM. The UNOS Scientific Renal Transplant Registry. In: Cecka JM, Terasaki PI. Clinical Transplants. Los Angeles: UCLA Immunogenetics Center, 1999: 1 – 21. | en_US |
dc.identifier.citedreference | Meier-Kriesche HU, Ojo AO, Cibrik DM et al. Relationship of recipient age and development of chronic allograft failure. Transplantation 2000; 70: 306 – 310. | en_US |
dc.identifier.citedreference | Meier–Kriesche HU, Ojo AO, Leichtman AB et al. Interaction of mycophenolate mofetil and HLA matching on renal allograft survival. Transplantation 2001; 71: 398 – 401. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe its collections in a way that respects the people and communities who create, use, and are represented in them. We encourage you to Contact Us anonymously if you encounter harmful or problematic language in catalog records or finding aids. More information about our policies and practices is available at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.